98%
921
2 minutes
20
Introduction: Risk assessment tools are increasingly employed at the policing stage to consider health-related needs and predict crime outcomes such as repeat intimate partner violence (IPV). Decisions informed by these tools can influence health outcomes, disproportionately affecting certain groups and potentially exacerbating health inequalities. However, their predictive accuracy, quality, and reliability remain uncertain.
Methods: Following PRISMA guidelines, we conducted a systematic review of development/derivation and validation studies on risk assessment tools used at the policing stage to evaluate health and crime outcomes.
Results: We identified 29 studies with 256,125 participants, reporting performance measures for 28 different tools for a range of health related and crime outcomes. The most common assessment was risk of IPV (18 studies or 62 %), and three studies (10 %) considered other health-related outcomes. Pooled estimates for outcomes ranged from 0.64 to 0.73, representing poor to moderate performance. The tools for predicting IPV demonstrated the weakest performance with a pooled AUC of 0.64 (95 % CI: 0.62, 0.66). The reporting of other performance measures beyond the AUC, such as true and false positives and negatives, and calibration was inadequate.
Conclusions: Current evidence for the routine use of existing risk assessment tools at the policing stage is limited. Some newer tools, developed with robust methodologies, show high predictive performance. Research should prioritize the development, validation, and implementation of these newer tools, particularly for outcomes with significant morbidity and mortality, such as IPV victimization. Implementing higher quality tools could reduce health inequalities by fostering more consistent decision-making and efficient resource allocation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.socscimed.2025.118457 | DOI Listing |
Circ Cardiovasc Interv
September 2025
Keele Cardiovascular Research Group, Keele University, United Kingdom (M.A.M., R.B.).
Background: Evidence informing clinical guidelines assumes that all transcatheter aortic valve implantation (TAVI) devices have similar effectiveness, in other words, displaying a class effect across TAVI valves. We aimed to assess the comparative effectiveness of different TAVI platforms relative to other TAVI counterparts or surgical aortic valve replacement (SAVR).
Methods: MEDLINE/Embase/CENTRAL were searched from inception until April 2025, for randomized controlled trials comparing outcomes with different commercially available TAVI devices relative to other TAVI counterparts or SAVR.
Crit Rev Toxicol
September 2025
Centre for Health Protection, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
There is a concern on the safety of cosmetic ingredients and their endocrine-disrupting (ED) potential. Frequent use as well as the use of a diverse range of cosmetics pose a concern for a potential health risk via aggregate exposure to endocrine disrupting chemicals (EDCs). In this study, a list of ingredients available in cosmetic products that were recently introduced to the Dutch market was retrieved from the commercially accessible Mintel database and screened for the presence of EDCs.
View Article and Find Full Text PDFRev Med Liege
September 2025
Service de Chimie clinique, CHU Liège, Belgique.
Chronic kidney disease (CKD), heart failure (HF) and atherosclerotic cardiovascular disease (ASCVD) are pathologies that may remain silent for a long time and thus are largely underdiagnosed in clinical practice. The use of biomarkers may help detect people already suffering from these diseases at an early stage or at increased risk to develop them in a near future. The aim of this article is to discuss the place of the assays of albuminuria, natriuretic peptide (BNP/proBNP) and high-sensitivity troponin as well as lipoprotein(a) to help in the diagnosis and prognosis assessment of individuals at risk of presenting or developing a CKD, HF or ASCVD.
View Article and Find Full Text PDFJ Dance Med Sci
September 2025
Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
The aim of this study was to propose reference values for the Dynamic Evaluation Method of Lower Limb Joint Alignment (MADAAMI II). During the 2023 Joinville Dance Festival, 346 dancers (315 females and 31 males), aged between 15 and 58 years, with a minimum of 5 years of ballet experience, were randomly evaluated. The dancers were filmed performing the three-step sequence (demi plié, grand plié, and fondu) of the MADAAMI II, in the first foot position, with self-selected turnout and at 120 degrees.
View Article and Find Full Text PDFKnee Surg Relat Res
September 2025
Florida Orthopaedic Institute, Gainesville, FL, 32607, USA.
Background: A clear understanding of minimal clinically important difference (MCID) and substantial clinical benefit (SCB) is essential for effectively implementing patient-reported outcome measurements (PROMs) as a performance measure for total knee arthroplasty (TKA). Since not achieving MCID and SCB may reflect suboptimal surgical benefit, the primary aim of this study was to use machine learning to predict patients who may not achieve the threshold-based outcomes (i.e.
View Article and Find Full Text PDF